Skip to content

Comparison of Two New Generations Dressings in Intensive Care Unit

Comparison Between Two New Generation Dressings in the Prevention of Intravascular Catheter Related Complications in Intensive Care Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01795391
Acronym
Advanced
Enrollment
685
Registered
2013-02-20
Start date
2012-10-31
Completion date
2013-11-30
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Related Complications

Keywords

Prevention, Dressings, Catheters

Brief summary

Intravascular devices in intensive care units are often associated to complications. The investigators estimate that 23.5% of catheters placed and used in intensive care are subject to at least one complication; the goal is to demonstrate the effectiveness of the new Tegaderm ™ IV Advanced dressings to achieve a decrease of 35% in the number of complications associated with intravascular catheters in intensive care.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years with a central venous catheter, an arterial catheter, a hemodialysis catheter, a Swan Ganz catheter or a peripheral catheter inserted in the ICU or within the 24 before their arrival at the ICU in another ICU setting. * Patients benefiting from the social security protection.

Exclusion criteria

* Patients under 18 years of age, * Patients having known allergy or sensitivity to adhesive dressing materials

Design outcomes

Primary

MeasureTime frame
Number of catheters presenting any kind of complications.From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.

Secondary

MeasureTime frame
Number of infections related to poor adherent dressings.From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.

Other

MeasureTime frame
Number of participants presenting allergic adverse events.From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.
Cost of each dressing type strategy.From the insertion of the catheter to its removal, an average time frame thant can go up to 4 weeks.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026